US Omeprazole import prices strengthened during the first half of May 2026 as higher quotations from major Asian suppliers, particularly China and India, increased import costs for US buyers. Rising crude oil prices, elevated freight charges, and tightening offshore allocations continued to support bullish sentiment in the Omeprazole market. Importers along the US Gulf Coast remained active in securing prompt cargoes as inventories stayed below normal levels, reinforcing upward pressure on landed costs. The firm market conditions followed the strong upward trend observed throughout April, when FDA quality-assurance audits and warning-letter follow-ups slowed batch releases at several offshore manufacturing facilities. At the same time, Indian and Chinese producers operated below seasonal production levels and prioritized higher-margin domestic formulations, reducing export availability for Omeprazole cargoes. Demand remained healthy across retail pharmacies, wholesalers, and procurement groups, supported by steady proton-pump inhibitor consumption and buffer-stock building ahead of tender cycles. Looking ahead, Omeprazole prices could witness further increases in the second half of May if logistics disruptions, elevated feedstock costs, and constrained offshore supply continue.
